The global manufacturing execution system market size is estimated to be worth USD 3.99 billion in 2024 and is anticipated to reach USD 20.46 billion by 2035 at a CAGR of 16.02% during the forecast period.

Manufacturing Execution System providers in healthcare market is the rising realm amongst stakeholders in pursuit to connect, monitor and control the complex manufacturing process. Every year, the healthcare industry generates a massive amount of data. In fact, the healthcare data currently constitutes around 30% share of the global data volume. Further, it is estimated that, by 2025, the data generated via the healthcare sector will rise at a compound annual growth rate of 36%.

However, it is important to consider that the constant management of such enormous volumes of data is a quite tedious process and challenging process. Specifically, management and handling of huge datasets in the healthcare industry often requires a large workforce of specialized personnel. According to the American Hospital Association, by 2026, there is likely to be a shortage of 3.2 million healthcare workers.  The continuously growing data, coupled to the projected deficit of healthcare workers, would inadvertently generate pressure on healthcare manufacturers to adopt novel tools / technologies that can improve management efficiency and better utilize the available, expensive resources.

Moreover, increasing complexity of healthcare manufacturing operations, along with growing stringency and frequent changes in regulatory requirements has created a dire need for adoption of automated solutions, such as manufacturing execution system (MES).

According to industry experts, MES has the potential to reduce 10%-30% of the overall production cost depending on the type of industry.  It has further been observed that companies are increasingly adopting cloud-based manufacturing execution system, to overcome the challenges associated with growing complexity of processes and global expansion of businesses.  Specifically, cloud-based MES integrates real-time information of different production floors and promotes collaboration.  Driven by the ongoing innovation in the industry, as well as the rise in demand for automated solutions, the manufacturing execution system providers market for the healthcare sector is likely to witness positive growth over the coming years.

Presently, more than 75 companies across the globe claim to offer manufacturing execution system for the healthcare sector in order to monitor, track and control the production process.

The market is characterized by the presence of very large companies (more than 10,000 employees), large players (501-10,000 employees), mid-sized companies (51-500 employees) and small companies (less than 50 employees). It is worth mentioning that mid-sized companies are pre-dominantly contributing to this field. Notably, the industry has also witnessed contributions from several very large firms such as (in alphabetical order) Dassault Systèmes, Emerson, Honeywell and Samsung SDS.

Europe emerged as the most prominent region wherein majority of the manufacturing execution system providers are located. This is followed by players that are based in North America. Examples of players based in North America include iBASEt and Oracle.

It is worth mentioning that majority of MES providers integrate enterprise resource planning (ERP) software with MES followed by product lifecycle management (PLM). To cope up with the current and future market demand, manufacturing execution system providers are actively collaborating with various stakeholders across the globe.

During our research, we came across several partnerships and collaborations that have been inked between various stakeholders engaged in providing manufacturing execution system. Out of all the partnerships, technology integration agreement has emerged as the most popular type of partnership signed by players engaged in providing manufacturing execution system. The industry has also witnessed seven instances of acquisitions in the given time period. This trend reflects the fact that companies are continuously striving to expand their existing service offerings. It is worth highlighting that the stakeholders in this industry are increasingly establishing long term strategic collaborations to better align their service offerings with the current market demand.

It was observed that majority of the deals (both local and international) were inked by players based in the Europe. Further, in most (~24%) of the intercontinental agreements, the service provider was observed to be based in Europe, while its collaborator was headquartered in North America.

It is worth mentioning that pharmaceutical and lifescience / biotechnology companies are its most prominent end users. In addition, the company has signed partnerships during the period 2018-2022. Examples of other prominent small players in this domain include (arranged in decreasing order of competitiveness) GE Digital and Aveva. It is also worth mentioning that a majority of firms in this peer group are based in North America.

Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.

To view more details on this report, click on the link

https://www.rootsanalysis.***/reports/manufacturing-execution-systems-market.html

Browse More Related Reports

https://pad.stuvus.uni-stuttgart.de/s/GxrOPSED1

https://hedgedoc.eclair.ec-lyon.fr/s/0nq9v2S8S

https://pad.ufc.tu-dortmund.de/s/-y0o6q3iC

https://pad.stuve.uni-ulm.de/s/CZ6qTPE1P

https://bpcnitrkl.in/members/gayle786/

https://hedge.fachschaft.informatik.uni-kl.de/s/grkB9Wtao

https://www.wowonder.xyz/read-blog/103573

https://webyourself.eu/blogs/526351/Cancer-Biomarker-Market-Trends-Opportunities-Key-Players-Growth-Factors-Revenue

https://ai.ceo/read-blog/196445

https://www.muamat.***/classifieds/54/posts/1_Services/8_Health_Personal_Trainer/45512691_Cancer_Biomarker_Market_Size_Share_Growth_Factors_Competitive_Landscape_with_Regional_Forecast_.html

https://www.addonface.***/post/366466_cancer-biomarker-market-size-demand-analytical-overview-comprehensive-analysis-s.html

https://sites.google.***/view/cancer-biomarker/home

https://kyourc.***/post/158051_cancer-biomarker-market-research-is-expecting-to-accrue-strong-growth-in-forecas.html

https://gargvidhi.copiny.***/idea/details/id/205183

https://hackmd.io/@Xdjgm_dJRIuJG-6hOg1nlg/BJAc9BZ11e

https://www.hostreview.***/blog/241007-cancer-biomarker-market-share-global-industry-size-trends-technology-and-analysis-by-2035

https://justpaste.me/xmJQ2

https://garg.muragon.***/entry/11.html

https://scrapbox.io/garg/Cancer_Biomarker__Market_-_Current_Impact_to_Make_Big_Changes_by_2035

https://collectednotes.***/garg/cancer-biomarker-market-growth-and-status-explored-in-a-new-research-report-2035

https://garg-2.federatedjournals.***/cancer-biomarker-market-extensive-industry-analysis-growth-rate-segmentation-investment-opportunities-and-top-manufacturers-2035/

https://gargvidhi123.pixnet.net/blog/post/163965151

https://blog.wenxuecity.***/myblog/81712/202410/4735.html

https://bresdel.***/blogs/728774/Cancer-Biomarker-Market-Report-by-Worldwide-Market-Trends-Opportunities-and

https://yamcode.***/garg-66347

https://youdontneedwp.***/garg/my-new-post-22bb4d9b-c6ad-427a-8b83-3001c2fe5046

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.

Contact:

Roots Analysis

+1 (415) 800 3415

Sales@rootsanalysis.***